These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8561474)

  • 21. The squalestatins: novel inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C1-modified analogues.
    Procopiou PA; Bailey EJ; Bamford MJ; Craven AP; Dymock BW; Houston JG; Hutson JL; Kirk BE; McCarthy AD; Sareen M
    J Med Chem; 1994 Sep; 37(20):3274-81. PubMed ID: 7932554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level.
    Peffley DM; Gayen AK
    Arch Biochem Biophys; 1997 Jan; 337(2):251-60. PubMed ID: 9016820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular docking studies to map the binding site of squalene synthase inhibitors on dehydrosqualene synthase of Staphylococcus aureus.
    Kahlon AK; Roy S; Sharma A
    J Biomol Struct Dyn; 2010 Oct; 28(2):201-10. PubMed ID: 20645653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total synthesis of the squalene synthase inhibitor zaragozic acid C by a carbonyl ylide cycloaddition strategy.
    Nakamura S; Hirata Y; Kurosaki T; Anada M; Kataoka O; Kitagaki S; Hashimoto S
    Angew Chem Int Ed Engl; 2003 Nov; 42(43):5351-5. PubMed ID: 14613174
    [No Abstract]   [Full Text] [Related]  

  • 25. Binding modes of zaragozic acid A to human squalene synthase and staphylococcal dehydrosqualene synthase.
    Liu CI; Jeng WY; Chang WJ; Ko TP; Wang AH
    J Biol Chem; 2012 May; 287(22):18750-7. PubMed ID: 22474324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibition.
    Biftu T; Acton JJ; Berger GD; Bergstrom JD; Dufresne C; Kurtz MM; Marquis RW; Parsons WH; Rew DR; Wilson KE
    J Med Chem; 1994 Feb; 37(3):421-4. PubMed ID: 8308869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationships of C1 and C6 side chains of zaragozic acid A derivatives.
    Ponpipom MM; Girotra NN; Bugianesi RL; Roberts CD; Berger GD; Burk RM; Marquis RW; Parsons WH; Bartizal KF; Bergstom JD
    J Med Chem; 1994 Nov; 37(23):4031-51. PubMed ID: 7966163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. III. Biosynthesis.
    Jones CA; Sidebottom PJ; Cannell RJ; Noble D; Rudd BA
    J Antibiot (Tokyo); 1992 Sep; 45(9):1492-8. PubMed ID: 1429235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclopentanedi- and tricarboxylic acids as squalene synthase inhibitors: syntheses and evaluation.
    Shen W; Garvey DS; Cohen J; Stein H; Rosenberg SH
    Bioorg Med Chem Lett; 1998 Apr; 8(8):891-6. PubMed ID: 9871507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS.
    Henneman L; van Cruchten AG; Kulik W; Waterham HR
    Biochim Biophys Acta; 2011 Apr; 1811(4):227-33. PubMed ID: 21237288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. V. Minor metabolites.
    Blows WM; Foster G; Lane SJ; Noble D; Piercey JE; Sidebottom PJ; Webb G
    J Antibiot (Tokyo); 1994 Jul; 47(7):740-54. PubMed ID: 8071119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total synthesis of the squalene synthase inhibitor zaragozic acid C.
    Nakamura S
    Chem Pharm Bull (Tokyo); 2005 Jan; 53(1):1-10. PubMed ID: 15635219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of the inhibition of rat and tobacco squalene synthase by squalestatins.
    Fulton DC; Tait M; Threlfall DR
    Phytochemistry; 1995 Mar; 38(5):1137-41. PubMed ID: 7766395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
    Keller RK; Zhao Z; Chambers C; Ness GC
    Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Link between cholesterol levels and phenobarbital induction of cytochromes P450.
    Ourlin JC; Handschin C; Kaufmann M; Meyer UA
    Biochem Biophys Res Commun; 2002 Feb; 291(2):378-84. PubMed ID: 11846416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ergosterol biosynthesis inhibitor zaragozic acid promotes vacuolar degradation of the tryptophan permease Tat2p in yeast.
    Daicho K; Maruyama H; Suzuki A; Ueno M; Uritani M; Ushimaru T
    Biochim Biophys Acta; 2007 Jul; 1768(7):1681-90. PubMed ID: 17531951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of novel tricyclic compounds as squalene synthase inhibitors.
    Ichikawa M; Ohtsuka M; Ohki H; Haginoya N; Itoh M; Sugita K; Usui H; Suzuki M; Terayama K; Kanda A
    Bioorg Med Chem; 2012 May; 20(9):3072-93. PubMed ID: 22464687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. IV. Preparation of fluorinated squalestatins by directed biosynthesis.
    Cannell RJ; Dawson MJ; Hale RS; Hall RM; Noble D; Lynn S; Taylor NL
    J Antibiot (Tokyo); 1993 Sep; 46(9):1381-9. PubMed ID: 8226317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo.
    Baxter A; Fitzgerald BJ; Hutson JL; McCarthy AD; Motteram JM; Ross BC; Sapra M; Snowden MA; Watson NS; Williams RJ
    J Biol Chem; 1992 Jun; 267(17):11705-8. PubMed ID: 1601846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.